ALPHYN
Live / Registered — Registered (as of 03 Jun 2025)
What this means for you
Registered since 03 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98443137
- Registration number
- 7820723
- Mark type
- Design + words
- Filed
- 11 Mar 2024
- Published for opposition
- 19 Nov 2024
- Registered
- 03 Jun 2025
- Attorney of record
- Michael J. Hertz
Goods and services
- Class 042 — Scientific and technological services: Research and development of drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development
Owner
- Alphyn Biologics, Inc., Annapolis, MD, US
- Alphyn Biologics, Inc., Annapolis, MD, US
- Alphyn Biologics, Inc., Annapolis, MD, US
Prior registrations
Prosecution history
- 03 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 15 May 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 May 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Apr 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jan 2025 — USE AMENDMENT FILED
- 12 Apr 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jan 2025 — TEAS STATEMENT OF USE RECEIVED
- 31 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Nov 2024 — PUBLISHED FOR OPPOSITION
- 13 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Sept 2024 — ASSIGNED TO EXAMINER
- 26 Jul 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED